Program Overview
In this module, John Brandsema MD, along with Claudia Chiriboga, MD, MPH, course chair, will review information released at the Virtual CureSMA Conference 2020. Dr. Brandsema will provide an in-depth overview of recent clinical trial data of current and emerging therapeutics for SMA, and the expert faculty will dive into a discussion on the details of these clinical trials and clinical implications. Upon completion of this 30-minute module, learners will better understand current and emerging clinical trial data of therapeutics for SMA, including information released at the Virtual CureSMA Conference 2020.
Target Audience
Neurologists, pediatricians, geneticists, primary care physicians, nurses, NPs, PAs, pharmacists, and other healthcare providers involved in the management of patients with SMA
Learning Objective
- Analyze recent clinical trial data, including data released at CureSMA 2020, of current and emerging therapeutics for SMA
Faculty
Claudia A. Chiriboga, MD, MPH
Professor of Neurology
Columbia University
New York, NY
John Brandsema, MD
Attending Physician
Neuromuscular/General Neurology & Electromyography
Neuromuscular Education Director and Neuromuscular Section Head
Children’s Hospital of Philadelphia
Philadelphia, PA
Disclosures of Conflict of Interest
It is the policy of AcademicCME that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:
| Faculty | Relationship Identified With: |
| Claudia A. Chiriboga, MD, MPH
|
Consultant/Advisor: AveXis, Inc.; Biogen; Cytokinetics, Inc.; F. Hoffmann-La Roche Ltd.
Grant/Research Support: AveXis, Inc.; Biogen; F. Hoffmann-La Roche Ltd. Speaker’s Bureau: Biogen |
| John Brandsema, MD | Consultant/Advisor: AveXis, Inc.; Biogen; Cytokinetics, Inc.; Genentech, USA Inc.
Grant/Research Support: AveXis, Inc.; Biogen Speaker’s Bureau: AveXis, Inc.; Biogen |
Planners and Peer Reviewers
Timothy Hayes, MD, PhD; Kim Cheramie, MSN, RN-BC; Nicole McMenamin and Chelsey Benedek hereby state that they or their spouse/life partner do not have any financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.
Accreditation Statement
In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. This activity was planned by and for the healthcare team.
Credit Designation Statements
AcademicCME designates this live material for a maximum of 0.50 AMA PRA Category 1 Credits TM.
Participants should claim only the credit commensurate with the extent of their participation in the activity.
Financial Support
This activity has been supported by an independent educational grant from Biogen
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Biogen do not recommend the use of any agent outside of the labeled indications.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Method of Participation
In order to claim credit, participants must complete the following:
- Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
- Complete the Pre-Activity Questions
- Read or Review the activity content.
- Complete the Post-Activity Test Questions and Evaluation.
- Learners who receive a grade of 66% or better on the Post-Activity Test Questions and complete the Evaluation will receive appropriate credit as indicated (CME, CNE, and/or CPE credit).
- CPE credit will be posted to the learner’s CPE Monitor profile within 60 days of completion.
- CME and CNE credit will be issued appropriate certificate of completion.
- Others may request a “certificate of completion”.
- Learners should claim only the credit commensurate with the extent of their participation in the activity.
CE Inquiries/Special Needs
For all CE inquiries or special needs, please contact [email protected].
